{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:34:25Z","timestamp":1757612065778,"version":"3.44.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"DOI":"10.7759\/cureus.91580","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T07:38:47Z","timestamp":1756971527000},"source":"Crossref","is-referenced-by-count":0,"title":["Tofacitinib-Induced Steroid-Free Remission in Subcutaneous Sarcoidosis With Neurologic Involvement: A Case Report"],"prefix":"10.7759","author":[{"given":"Dan","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenrui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi MC","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007, 357:2153-65. 10.1056\/NEJMra071714","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3356-0","article-title":"Subcutaneous sarcoidosis: a clinical analysis of nine patients","volume":"35","author":"Ando M","year":"2016","unstructured":"Ando M, Miyazaki E, Hatano Y, et al.. Subcutaneous sarcoidosis: a clinical analysis of nine patients. Clin Rheumatol. 2016, 35:2277-81. 10.1007\/s10067-016-3356-0","journal-title":"Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12046-w","article-title":"Neurosarcoidosis","volume":"271","author":"Kidd DP","year":"2024","unstructured":"Kidd DP. Neurosarcoidosis. J Neurol. 2024, 271:1047-55. 10.1007\/s00415-023-12046-w","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106081","article-title":"Corticosteroid refractory sarcoidosis","volume":"171","author":"Goldman C","year":"2020","unstructured":"Goldman C, Judson MA. Corticosteroid refractory sarcoidosis. Respir Med. 2020, 171:106081. 10.1016\/j.rmed.2020.106081","journal-title":"Respir Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30615-x","article-title":"Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis","volume":"13","author":"Damsky W","year":"2022","unstructured":"Damsky W, Wang A, Kim DJ, et al.. Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nat Commun. 2022, 13:3140. 10.1038\/s41467-022-30615-x","journal-title":"Nat Commun"},{"key":"ref6","article-title":"The promise of JAK inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature","volume":"93","author":"Wang A","year":"2020","unstructured":"Wang A, Singh K, Ibrahim W, King B, Damsky W. The promise of JAK inhibitors for treatment of sarcoidosis and other inflammatory disorders with macrophage activation: a review of the literature. Yale J Biol Med. 2020, 93:187-95.","journal-title":"Yale J Biol Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805958","article-title":"Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis","volume":"379","author":"Damsky W","year":"2018","unstructured":"Damsky W, Thakral D, Emeagwali N, Galan A, King B. Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis. N Engl J Med. 2018, 379:2540-6. 10.1056\/NEJMoa1805958","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.098","article-title":"Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare","volume":"82","author":"Damsky W","year":"2020","unstructured":"Damsky W, Thakral D, McGeary MK, Leventhal J, Galan A, King B. Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare. J Am Acad Dermatol. 2020, 82:612-21. 10.1016\/j.jaad.2019.05.098","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11112","article-title":"Treatment of multiorgan sarcoidosis with tofacitinib","volume":"2","author":"Damsky W","year":"2020","unstructured":"Damsky W, Young BD, Sloan B, Miller EJ, Obando JA, King B. Treatment of multiorgan sarcoidosis with tofacitinib. ACR Open Rheumatol. 2020, 2:106-9. 10.1002\/acr2.11112","journal-title":"ACR Open Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.10.016","article-title":"Tofacitinib for cutaneous and pulmonary sarcoidosis: a case series","volume":"84","author":"Kerkemeyer KL","year":"2021","unstructured":"Kerkemeyer KL, Meah N, Sinclair RD. Tofacitinib for cutaneous and pulmonary sarcoidosis: a case series. J Am Acad Dermatol. 2021, 84:581-3. 10.1016\/j.jaad.2020.10.016","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-021-00436-8","article-title":"Tofacitinib as a steroid-sparing therapy in pulmonary sarcoidosis, an open-label prospective proof-of-concept study","volume":"199","author":"Friedman MA","year":"2021","unstructured":"Friedman MA, Le B, Stevens J, et al.. Tofacitinib as a steroid-sparing therapy in pulmonary sarcoidosis, an open-label prospective proof-of-concept study. Lung. 2021, 199:147-53. 10.1007\/s00408-021-00436-8","journal-title":"Lung"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/396327-tofacitinib-induced-steroid-free-remission-in-subcutaneous-sarcoidosis-with-neurologic-involvement-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T07:38:47Z","timestamp":1756971527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/396327-tofacitinib-induced-steroid-free-remission-in-subcutaneous-sarcoidosis-with-neurologic-involvement-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.91580","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}